|
| 36538063 | High-throughput genetic clustering of type 2 diabetes loci reveals heterogeneous mechanistic pathways of metabolic disease. | | 2023 |
| 37024582 | Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer. | Nat Genet | 2023 |
| 36697832 | Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. | Nature | 2023 |
| 36697836 | Author Correction: The repertoire of mutational signatures in human cancer. | Nature | 2023 |
| 35243413 | Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma. | Cell Rep Med | 2022 |
| 36040373 | High-Resolution Profiling of Lung Adenocarcinoma Identifies Expression Subtypes with Specific Biomarkers and Clinically Relevant Vulnerabilities. | Cancer Res | 2022 |
| 36075914 | Biomarker correlates with response to NY-ESO-1 TCR T cells in patients with synovial sarcoma. | Nature Communications | 2022 |
| 34426670 | Genetic analysis of dietary intake identifies new loci and functional links with metabolic traits. | Nat Hum Behav | 2022 |
| 33051600 | Subependymal giant cell astrocytomas are characterized by mTORC1 hyperactivation, a very low somatic mutation rate, and a unique gene expression profile. | Mod Pathol | 2021 |
| 32868381 | Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non-Muscle-Invasive Bladder Cancer. | Cancer Res | 2020 |
| 31857723 | A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinoma. | Br J Cancer | 2020 |
| 32025018 | The repertoire of mutational signatures in human cancer. | Nature | 2020 |
| 32037144 | Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434-5. | Eur Urol | 2020 |
| 30851984 | The Cancer Genome Atlas Expression Subtypes Stratify Response to Checkpoint Inhibition in Advanced Urothelial Cancer and Identify a Subset of Patients with High Survival Probability. | Eur Urol | 2019 |
| 31697821 | Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade. | Blood | 2019 |
| 31675989 | Scaling computational genomics to millions of individuals with GPUs. | Genome Biol | 2019 |
| 31816062 | Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion. | Blood Adv | 2019 |
| 30593515 | Mutational Analysis of 472 Urothelial Carcinoma Across Grades and Anatomic Sites. | Clin Cancer Res | 2019 |
| 31526759 | Passenger Hotspot Mutations in Cancer. | Cancer Cell | 2019 |
| 31171663 | RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues. | Science | 2019 |
| 31068700 | Next-generation characterization of the Cancer Cell Line Encyclopedia. | Nature | 2019 |
| 29360550 | Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations. | J Hepatol | 2018 |
| 33604497 | Sequential Response to <i>FGFR3</i> Inhibition With Subsequent Exceptional Response to Atezolizumab in a Patient With <i>FGFR3-TACC3</i> Fusion-Positive Metastatic Urothelial Carcinoma. | JCO Precis Oncol | 2018 |
| 30459213 | Quantification of somatic mutation flow across individual cell division events by lineage sequencing. | Genome Res | 2018 |
| 30224644 | Mutational processes shape the landscape of TP53 mutations in human cancer. | Nat Genet | 2018 |
| 30107175 | Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma. | Cancer Cell | 2018 |
| 30096302 | Comprehensive Characterization of Cancer Driver Genes and Mutations. | Cell | 2018 |
| 30096301 | Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. | Cell | 2018 |
| 30240442 | Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: A soft clustering analysis. | PLoS Med | 2018 |
| 29955181 | Publisher Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. | Nat Med | 2018 |
| 29955182 | Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. | Nat Med | 2018 |
| 29903880 | Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine. | Cancer Discov | 2018 |
| 29724721 | <i>SETD2</i> Is Recurrently Mutated in Whole-Exome Sequenced Canine Osteosarcoma. | Cancer Res | 2018 |
| 29625053 | Comprehensive Characterization of Cancer Driver Genes and Mutations. | Cell | 2018 |
| 29625049 | Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics. | Cell | 2018 |
| 29717118 | Distinct mutational signatures characterize concurrent loss of polymerase proofreading and mismatch repair. | Nat Commun | 2018 |
| 29622466 | Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. | Cancer Cell | 2018 |
| 29713087 | Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. | Nat Med | 2018 |
| 29438696 | The Integrated Genomic Landscape of Thymic Epithelial Tumors. | Cancer Cell | 2018 |
| 27852700 | Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma. | Clin Cancer Res | 2017 |
| 28825726 | A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer. | Nat Genet | 2017 |
| 28988769 | Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. | Cell | 2017 |
| 28658208 | Recurrent and functional regulatory mutations in breast cancer. | Nature | 2017 |
| 28522256 | Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers. | Gastroenterology | 2017 |
| 28352639 | Racial Differences in Expression Levels of miRNA Machinery-Related Genes, Dicer, Drosha, DGCR8, and AGO2, in Asian Korean Papillary Thyroid Carcinoma and Comparative Validation Using the Cancer Genome Atlas. | International Journal of Genomics | 2017 |
| 29259186 | Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer. | Nat Commun | 2017 |
| 29109393 | Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors. | Nat Commun | 2017 |
| 27494029 | Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development. | PLoS Genet | 2016 |
| 26755726 | Regulation of Transient Site-specific Copy Gain by MicroRNA. | J Biol Chem | 2016 |
| 27111033 | Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors. | Nat Genet | 2016 |